As the first dual GIP/GLP-1 receptor agonist, tirzepatide represents a significant advancement in metabolic therapeutics, offering enhanced efficacy compared to single-pathway agents
Giachelli C.M., Lombardi D., Johnson R.J., Murry C.E
If you do find yourself needing to shift your injection day by a day or two, contact PlexusDx support to adjust your standing schedule going forward
The findings consistently indicate no benefit and, in some cases, a worsening of CIPN with LC use
Stay tuned for updates on our advanced peptide products, and remember, were here to help you achieve your health goals
The medication might help optimise these genes function, though this is based on general GLP-1 research rather than Mounjaro-specific studies